ClinicalTrials.gg
Not yet recruitingNCT07750028QuickDASH-CATUpdated Aug 6, 2026

Catalan Translation and Psychometric Validation of the QuickDASH

An observational study in Upper Extremity Disorders, sponsored by Corporacion Parc Tauli. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Corporacion Parc Tauli · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Patient-reported outcome measures (PROMs) are essential tools for assessing upper extremity disability from the patient's perspective and are increasingly incorporated into routine clinical practice and research. The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is one of the most widely used PROMs in upper limb surgery worldwide. Although the questionnaire has been translated and validated into multiple languages, no officially translated and psychometrically validated Catalan version is currently available. The aim of this study is to translate, cross-culturally adapt and psychometrically validate the Catalan version of the QuickDASH according to internationally accepted recommendations for PROM translation and validation. The project consists of two sequential phases. Phase I comprises forward translation, synthesis, back-translation, expert committee review and cognitive debriefing. Phase II consists of a prospective observational psychometric validation study in Catalan-speaking adults with upper extremity disorders. The resulting instrument is expected to become the official Catalan version of the QuickDASH for use in clinical practice and research.

Read the detailed description

Patient-reported outcome measures (PROMs) have become an essential component of modern healthcare by providing standardized assessment of symptoms, disability and treatment outcomes directly from the patient's perspective. Their routine use has increased considerably during the last decade owing to recommendations from international scientific societies and their incorporation into both clinical research and routine outcome assessment. The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is among the most frequently used PROMs for evaluating upper extremity disability. Compared with the original 30-item DASH questionnaire, the abbreviated 11-item QuickDASH maintains excellent psychometric performance while substantially reducing respondent burden, facilitating its use in everyday clinical practice. Despite the widespread use of Catalan within the healthcare system in Catalonia, no officially translated and psychometrically validated Catalan version of the QuickDASH is currently available. Consequently, clinicians and researchers frequently rely on Spanish versions that may not fully reflect linguistic and cultural characteristics specific to Catalan-speaking populations. The primary objective of this study is to produce an officially translated, culturally adapted and psychometrically validated Catalan version of the QuickDASH following internationally accepted methodology and the recommendations established by the Institute for Work \& Health (IWH), copyright holder of the DASH and QuickDASH questionnaires. The translation process will include two independent forward translations, synthesis of both versions, two independent back-translations, multidisciplinary expert committee review and cognitive debriefing in Catalan-speaking patients. Once the final Catalan version has been established, a prospective observational validation study will evaluate its psychometric properties in approximately 100 adult patients presenting with upper extremity disorders at Parc Taulí Hospital Universitari. Psychometric evaluation will include assessment of internal consistency, test-retest reliability, construct validity, measurement error, responsiveness and floor and ceiling effects according to internationally accepted standards for PROM validation studies. The availability of an officially validated Catalan QuickDASH is expected to facilitate standardized outcome assessment in Catalan-speaking populations, improve comparability between international studies and promote the incorporation of patient-reported outcomes into routine clinical practice.

02

Conditions studied

  • Upper Extremity Disorders

Keywords

  • QuickDASH;
  • Disabilities of the Arm
  • Shoulder and Hand
  • Patient-Reported Outcome Measures
  • Outcome Assessment
  • PROM
  • Cross-cultural Adaptation
  • Translation
  • Validation Study
  • Questionnaire
  • Catalan
  • Psychometric Validation
  • Upper Extremity
03

In context

Lead sponsor

Corporacion Parc Tauli is the lead sponsor of 167 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult Catalan-speaking patients (18 years or older) presenting with an upper extremity musculoskeletal disorder (acute or chronic) at the outpatient upper extremity clinic of Parc Taulí Hospital Universitari (Sabadell, Spain), able to read and understand written Catalan and to provide written informed consent

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older. Native or fluent Catalan speaker. Diagnosis of an upper extremity musculoskeletal disorder requiring assessment using the QuickDASH questionnaire. Able to read and understand written Catalan. Able and willing to provide written . Able to complete the questionnaire independently.

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment preventing questionnaire completion. Severe neurological or psychiatric disorders interfering with questionnaire interpretation. Inability to read or understand Catalan. Refusal or inability to provide written . Any other condition that, in the opinion of the investigator, could compromise participation or interpretation of questionnaire results.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Catalan QuickDASH Validation Cohort

    Adult Catalan-speaking patients presenting with upper extremity disorders who will complete the Catalan version of the QuickDASH as part of the psychometric validation study. Participants will undergo questionnaire assessment at baseline and a subgroup will complete a second assessment for evaluation of test-retest reliability according to the study protocol.

06

What researchers measure

Primary outcomes

  1. Cross-cultural adaptation and psychometric validation of the Catalan QuickDASH

    Successful translation, cross-cultural adaptation and psychometric validation of the Catalan version of the Quick Disabilities of the Arm, Shoulder and Hand questionnaire following internationally accepted recommendations, including cognitive debriefing and expert committee review.

    Time frame: Baseline and completion of the translation and validation process (approximately 12 months).

07

Study locations

1 site
  • Parc Taulí Hospital Univesritari
    Sabadell, Barcelona 08208, Spain
    • Ana Scott-Tennent De Rivas, MD · Contactdra.anascotttennent@gmail.com · 0034-650574958
    • Francesc Mercano Fernandez, MD · Sub investigator
    • Jaume Camara Cabrera, PHD · Sub investigator
    • Nona Poy, MD · Sub investigator
    • Roger Rojas Sayol, MD · Sub investigator
    • Joan Miquel Noguera, PHD · Sub investigator
    • Ana Scott-Tennent De Rivas, MD · Principal investigator
08

References and documents

Publications

  • Mokkink LB, et al. COSMIN Study Design Checklist for Patient-reported Outcome Measurement Instruments. 2019.
  • Institute for Work & Health. Guidelines for the Translation and Cross-Cultural Adaptation of the DASH & QuickDASH Outcome Measures. Toronto: Institute for Work & Health; 2007.
  • Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001 Apr-Jun;14(2):128-46. PubMed 11382253 ↗

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared. Requests for access to anonymized data may be considered by the Principal Investigator and the sponsor on reasonable request, in accordance with institutional policies, ethical approval and applicable data protection regulations.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07750028
Collaborators
Federation of European Societies for Surgery of the Hand (FESSH)
Responsible party
Ana Scott-Tennent (Consultant, Orthopaedic Surgery and Traumatology, Corporacion Parc Tauli) — Principal investigator
First posted
Aug 6, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Aug 6, 2026

Study contacts

Ana Scott-Tennent De Rivas, MD
Contact
dra.anascotttennent@gmail.com
+34650574958
Ana Scott-Tennent De Rivas, MD
principal investigator · Institut d'Investigació i Innovació Parc Taulí (I3PT)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion